CCL20 induces migration and proliferation on breast epithelial cells

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Tumor cells communicate with surrounding cells, driving tumor progression.
• Breast cancer microenvironments contain CCL20 chemokine, suggesting a role in tumor-host interactions.

Purpose of the Study:

• To determine if CCL20 modulates the physiology of healthy breast epithelial cells adjacent to tumors.
• To investigate the signaling pathways involved in CCL20-mediated effects on breast cells.

Main Methods:

• Primary cultures of normal mammary cells from peritumoral areas were used.
• Cells were treated with varying concentrations of CCL20.
• Molecular techniques (siRNA) and pharmacological inhibitors were employed to study signaling pathways.
• Expression levels of key proteins and gene transcription factors were assessed.

Main Results:

• Breast cells express the CCL20 receptor, CCR6.
• CCL20 binding to CCR6 induced cell migration at 10 ng/ml and proliferation at higher concentrations (15-25 ng/ml).
• CCL20 activated multiple signaling kinases (PKC-alpha, Src, Akt, JNK, NF-kB, PKC-epsilon, EGFR, ERK1/2/MAPK) involved in migration and proliferation.
• CCL20 modulated cell cycle regulators (cycE, p27Kip) and transcription factors (c-fos, c-myc).

Conclusions:

• CCL20 signaling through CCR6 influences healthy breast cell migration and proliferation.
• The study identifies key molecular pathways (e.g., PKC, Src, Akt, MAPK) mediating CCL20's effects.
• CCL20 may play a role in the development and progression of breast carcinoma by altering the behavior of surrounding healthy cells.